- Antibody identifier could speed development of therapies for cancer, other diseases
A research team led by a UCLA bioengineer has developed a model to predict the extent to which new laboratory-designed antibodies will be able to combat specific human diseases.
July 09, 2018 10:00 AMdetail
- Carnegie Corporation names two UCLA professors “Great Immigrants”
The Carnegie Corporation of New York named two UCLA professors, Dr. Antoni Ribas and Marcelo Suárez-Orozco, “Great Immigrants” as part of a selected group of naturalized citizens who have made notable contributions to the progress of American society.
June 28, 2018 10:00 AMdetail
- UCLA partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers in the United States
Nearly 80 million Americans – one out of every four people – are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.
June 07, 2018 8:00 AMdetail
- Back on set
Meet writer and director Erika Kaestle, who under the care of UCLA Jonsson Comprehensive Cancer Center physician-scientist Dr. Timothy Cloughesy, keeps the production going even while battling brain cancer.
June 06, 2018 12:00 PMdetail
- Researchers discover how colon cancer mutates to escape the immune system
A UCLA-led study has found how colon cancer alters its genes during development in order to avoid detection by the immune system, creating a specific genetic imprint in the process.
June 03, 2018 6:00 AMdetail
- Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA and at Northwest Biotherapeutics, Inc. has found that a personalized glioblastoma vaccine may increase long-term survival in some patients. Nearly 30 percent of patients in the current trial have now survived at least three years post-enrollment, with patients continuing to be followed over time.
May 30, 2018 8:00 AMdetail
- New grant funds cutting-edge UCLA clinical trial for late-stage lung cancer
UCLA scientists have been awarded a $12M grant from the California Institute for Regenerative Medicine — also known as CIRM — to initiate a phase 1 clinical trial to test a novel cancer treatment for advanced-stage lung cancer.
May 29, 2018 8:30 AMdetail
- Melanoma researcher selected as AACR NextGen Star
Scientist Dr. Willy Hugo, adjunct assistant professor of medicine and dermatology, has been named as a NextGen Star by the American Association of Cancer Research for his efforts in finding new ways to tackle melanoma, the most deadly type of skin cancer.
May 24, 2018 9:30 AMdetail
- UCLA Jonsson Comprehensive Cancer Center physicians, scientists to present on latest cancer research advancements at ASCO annual meeting
Scientists at the UCLA Jonsson Comprehensive Cancer Center will be presenting on the latest advancements in clinical cancer research, alternative treatment options for late-stage cancers and the newest developments in immunotherapy at the Annual Meeting of the American Society of Clinical Oncology.
May 21, 2018 9:00 AMdetail
- UCLA professors elected to the National Academy of Sciences for 2018
Two UCLA professors, Utpal Banerjee and Andrea Bertozzi, were elected to the National Academy of Sciences today in recognition of their “distinguished and continuing achievements in original research.”
May 01, 2018 10:00 AMdetail
- Cancer researcher awarded $750,000 to help advance new treatments for melanoma
The American Skin Association has awarded Dr. Roger Lo, professor of dermatology and molecular and medical pharmacology in the UCLA David Geffen School of Medicine and a member of the UCLA Jonsson Comprehensive Cancer Center, with the Abby S. and Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma Skin Cancer Research.
May 01, 2018 9:00 AMdetail